KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aehr Test Systems (AEHR) Gains from Sales and Divestitures (2016 - 2025)

Aehr Test Systems (AEHR) has 10 years of Gains from Sales and Divestitures data on record, last reported at $76000.0 in Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 61.7% year-over-year to $76000.0; the TTM value through Nov 2025 reached $76000.0, up 61.7%, while the annual FY2025 figure was $194000.0, 14.12% up from the prior year.
  • Gains from Sales and Divestitures reached $76000.0 in Q4 2025 per AEHR's latest filing, up from $61000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $240000.0 in Q2 2023 and bottomed at $19.0 in Q1 2021.
  • Average Gains from Sales and Divestitures over 5 years is $94051.0, with a median of $72500.0 recorded in 2025.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 110426.32% in 2022, then plummeted 85.52% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $18000.0 in 2021, then skyrocketed by 233.33% to $60000.0 in 2022, then tumbled by 53.33% to $28000.0 in 2023, then skyrocketed by 67.86% to $47000.0 in 2024, then surged by 61.7% to $76000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $76000.0 in Q4 2025, $61000.0 in Q3 2025, and $194000.0 in Q2 2025.